시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 일차 세포배양 시장 보고서(2024년)
Primary Cell Culture Global Market Report 2024
상품코드 : 1522301
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 6,949,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,423,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 13,898,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

일차 세포배양 시장 규모는 향후 수년간 급성장이 전망됩니다. 2028년에는 CAGR 15%로 118억 9,000만 달러로 성장합니다. 예측 기간 중의 성장은 암 발병률의 급증, 제약 및 생명공학 산업의 확대, 맞춤형 의료에 대한 수요 증가, 3D 세포배양 모델에서의 응용 증가에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 제품 혁신, 파트너십, 연구개발 노력 등이 있습니다.

초기 세포배양 시장의 성장은 만성질환의 유병률 증가에 의해 주도될 것으로 예상됩니다. 만성질환은 천천히 진행되어 오랜 기간 중, 종종 개인의 일생 동안 지속되는 불치병입니다. 이러한 증가는 생활습관의 변화, 환경적 영향, 운동 부족, 식습관 변화, 인구 통계학적 변화 등의 요인에 기인합니다. 초기 배양 세포는 만성질환에 대한 지식과 치료 전략을 발전시키고 궁극적으로 환자의 결과를 개선하는 데 중요한 역할을 하고 있습니다. 예를 들어 2023년 1월 국립생명공학정보센터(National Center For Biotechnology Information)는 2020년 7,152만 2,000명에서 2050년 1억 4,266만 명으로 99.5% 증가할 것으로 예상했습니다. 증가할 것으로 예상하고 있습니다. 따라서 만성질환의 유병률 증가는 일차 세포배양 시장의 주요 촉진요인으로 작용하고 있습니다.

초기 세포배양 시장의 1차 개척자들은 지속가능하고 윤리적인 육류 생산 기술의 발전을 위해 배양육 연구 전용의 1차 세포를 포함한 세포은행 개발에 주력하고 있습니다. 세포은행 구상은 배양육 연구개발에 적합한 고품질의 동물 원시세포를 다른 세포주 프로바이더보다 최대 90% 저렴한 비용과 라이선스 제한 없이 제공함으로써 초기 단계의 기업과 연구자들을 지원하는 것을 목표로 하고 있습니다. 예를 들어 2023년 6월 영국의 CDMO인 엑스트라셀룰러(Extracellular)는 배양육 분야를 지원하기 위해 저비용, 무면허 세포은행을 도입했습니다. 이 세포 은행은 처음에는 소, 돼지, 양고기의 지방, 근육, 골수 조직에서 분리한 세포를 제공합니다. 이 공동 프로젝트는 세포주의 가용성을 높이고 라이선스 및 상업적 계약의 제약 없이 혁신적인 기술 개발을 가능하게 함으로써 영국의 배양육 산업의 성장을 가속화할 것으로 기대됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재적 분석

제36장 부록

KSA
영문 목차

영문목차

Primary cell culture involves isolating cells directly from tissues or organisms and cultivating them in a controlled laboratory setting. This process includes obtaining tissues from humans or animals, breaking them down using various methods, and encouraging viable cells to grow in specialized culture vessels with specific media.

The primary cell culture products primarily consist of primary cells, reagents, supplements, and media. Primary cells are valued for maintaining their original phenotype and functions, making them more representative of natural cells and providing reliable results that can be translated into in vivo applications with confidence. These products are used for both animal and human cells. Various techniques for separation and culture include the explant method, enzymatic disaggregation, mechanical separation, and others. They are applied in diverse fields such as tissue culture and engineering, vaccine production, gene therapy, regenerative medicine, drug screening, toxicity testing, cancer research, virology, stem cell therapy, among others. These products are utilized by pharmaceutical and biotechnology companies, academic and research institutes, and other end users.

The primary cell culture market research report is one of a series of new reports from The Business Research Company that provides primary cell culture market statistics, including primary cell culture industry global market size, regional shares, competitors with a primary cell culture market share, detailed primary cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the primary cell culture industry. This primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary cell culture market size has grown rapidly in recent years. It will grow from $5.91 billion in 2023 to $6.79 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to the increasing demand for monoclonal antibodies, the rise in demand for novel therapeutics, the growing popularity of personalized medicine, and the increasing interest in cell therapy research.

The primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $11.89 billion in 2028 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to the rapid increase in cancer incidence, the rising expansion of pharmaceutical and biotechnology industries, the growing demand for personalized medicine, and the increasing applications in 3D cell culture models. Major trends in the forecast period include technological advancements, product innovation, partnerships, and research and development efforts.

The growth of the primary cell culture market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases are enduring conditions that progress slowly and persist over extended periods, often throughout an individual's lifetime. This rise can be attributed to factors such as lifestyle changes, environmental influences, physical inactivity, dietary shifts, and demographic changes. Primary cell cultures play a crucial role in advancing knowledge and treatment strategies for chronic diseases, ultimately enhancing patient outcomes. For example, in January 2023, the National Center For Biotechnology Information estimated that the number of people with at least one chronic disease would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the increasing prevalence of chronic diseases is a key driver of the primary cell culture market.

Leading companies in the primary cell culture market are focusing on developing cell banks containing primary cells specifically for cultivated meat research, aiming to advance sustainable and ethical meat production technologies. The Cell Bank initiative aims to support early-stage companies and researchers by providing high-quality animal primary cells suitable for cultivated meat research and development, at up to 90% lower costs than other cell line providers and free from licensing restrictions. For instance, in June 2023, Extracellular, a UK-based CDMO, introduced low-cost, license-free cell banks to support the cultivated meat sector. These cell banks initially offer cells isolated from cows, pigs, and lambs' fat, muscle, and bone marrow tissues. This collaborative project accelerates the growth of the cultivated meat industry in the UK by increasing cell line availability and enabling innovative technology development without licensing or commercial agreement restrictions.

In April 2023, AnaBios Corporation acquired Cell Systems, further enhancing its portfolio of human tissue and cells to support drug discovery and deepen understanding of cell biology. Cell Systems, a US-based company, provides primary cell and cell culture solutions.

Major companies operating in the primary cell culture market are Thermo Fisher Scientific Inc., Merck KGaA , FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sarl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies

North America was the largest region in the primary cell culture market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The primary cell culture market consists of revenues earned by entities by provide services such as adherent cell culture service, suspension cell culture service, cell purification, and analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell culture market also includes sales of cell culture vessels, human platelet lysate, and cell culture plastics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Cell Culture Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for primary cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Scope

Table of Contents

1. Executive Summary

2. Primary Cell Culture Market Characteristics

3. Primary Cell Culture Market Trends And Strategies

4. Primary Cell Culture Market - Macro Economic Scenario

5. Global Primary Cell Culture Market Size and Growth

6. Primary Cell Culture Market Segmentation

7. Primary Cell Culture Market Regional And Country Analysis

8. Asia-Pacific Primary Cell Culture Market

9. China Primary Cell Culture Market

10. India Primary Cell Culture Market

11. Japan Primary Cell Culture Market

12. Australia Primary Cell Culture Market

13. Indonesia Primary Cell Culture Market

14. South Korea Primary Cell Culture Market

15. Western Europe Primary Cell Culture Market

16. UK Primary Cell Culture Market

17. Germany Primary Cell Culture Market

18. France Primary Cell Culture Market

19. Italy Primary Cell Culture Market

20. Spain Primary Cell Culture Market

21. Eastern Europe Primary Cell Culture Market

22. Russia Primary Cell Culture Market

23. North America Primary Cell Culture Market

24. USA Primary Cell Culture Market

25. Canada Primary Cell Culture Market

26. South America Primary Cell Culture Market

27. Brazil Primary Cell Culture Market

28. Middle East Primary Cell Culture Market

29. Africa Primary Cell Culture Market

30. Primary Cell Culture Market Competitive Landscape And Company Profiles

31. Primary Cell Culture Market Other Major And Innovative Companies

32. Global Primary Cell Culture Market Competitive Benchmarking

33. Global Primary Cell Culture Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Cell Culture Market

35. Primary Cell Culture Market Future Outlook and Potential Analysis

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기